New Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
Register now:
Bringing a Stand-Alone Immune Effector Cell therapy Program into Compliance
In This Issue
- Just the FACTs, Volume 4
- FACT, ASTCT, CIBMTR, ISCT, and EBMT Publish Joint Statement Against Racism
- FACT Announces New Quality Management Series, Module 10: Validations
- FACT-CBA Webinar: The Effect of the COVID-19 Pandemic on Cord Blood Banking
- FACT Annual Compliance
- COVID-19 Update: FACT Accreditation
- New Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
- FACT Cord Blood Inspection and Accreditation Workshop at the 2020 Cord Blood Connect International Congress Officially Cancelled
- Update for HRSA-contracted Cord Blood Banks
- Heat-sealing label in cryopreservation bag pouch meets definition of “Affix”
- FACT Accreditation a Criterion for 2020-2021 Best Children’s Hospitals List
accreditation statistics
As of April 1, 2021
Cellular Therapy Entities
- Accredited: 237
- Applicants: 21
Cord Blood Banks
- Accredited: 58
- Applicants: 8
A complete list of accredited organizations can be found at www.factwebsite.org.
Congratulations to the following organization for achieving its initial FACT accreditation:
GW Cancer Center Stem Cell Transplantation and Cellular Therapy Program, Washington, DC
Director: John Barrett, MD
Adult Autologous Hematopoietic Progenitor Cell Transplantation, Peripheral Blood Cellular Therapy Product
Collection, and Cellular Therapy Product Processing with Minimal Manipulation
